Institutional Investors May Overlook Nuvation Bio Inc.'s (NYSE:NUVB) Recent US$54m Market Cap Drop as Long-term Gains Remain Positive

Simply Wall StJan 1 22:04

Why Is Nuvation Bio (NUVB) the Best Biotech Penny Stock to Invest in Now?

Yahoo FinanceDec 31, 2024 04:00

Sector Update: Health Care Stocks Fall Premarket Monday

MT NewswiresDec 23, 2024 22:21

Nuvation Bio Announces The U.S. FDA Accepts For Priority Review Nuvation Bio's New Drug Application For Taletrectinib For The Treatment Of Advanced ROS1-Positive Non-Small Cell Lung Cancer

BenzingaDec 23, 2024 21:05

Express News | Nuvation Bio Inc - FDA Assigns Target Action Date of June 23, 2025

BreakingsDec 23, 2024 21:00

Express News | U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced Ros1-Positive Non-Small Cell Lung Cancer

BreakingsDec 23, 2024 21:00